Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;92:1115-1122
Published online before print May 1, 2003, doi: 10.1161/01.RES.0000074880.25540.D0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
92/10/1115    most recent
01.RES.0000074880.25540.D0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipskaia, L.
Right arrow Articles by Lompré, A.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipskaia, L.
Right arrow Articles by Lompré, A.-M.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Physiological and pathological control of gene expression
Right arrow Smooth muscle proliferation and differentiation
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2003;92:1115.)
© 2003 American Heart Association, Inc.


Molecular Medicine

Phosphatidylinositol 3-Kinase and Calcium-Activated Transcription Pathways Are Required for VLDL-Induced Smooth Muscle Cell Proliferation

Larissa Lipskaia, Marie-Luce Pourci, Claudine Deloménie, Laurent Combettes, Dominique Goudounèche, Jean-Louis Paul, Thierry Capiod, Anne-Marie Lompré

From INSERM U446 (L.L., C.D., A.-M.L.), Laboratoire de Biochimie Appliquée (M.-L.P., D.G., J.-L.P.) and IFR-75: Institut de signalisation et innovation thérapeutique, Faculté de Pharmacie, Châtenay-Malabry, France; and INSERM U442, IFR: Signalisation cellulaire (L.C., T.C.), Faculté des Sciences Bâtiment 443, Orsay, France.

Correspondence to Anne-Marie Lompré, INSERM U446/IFR-75, Institut de signalisation et innovation thérapeutique, Faculté de Pharmacie, Tour D4, 5 rue JB Clément, 92296 Châtenay-Malabry, France. E-mail anne-marie.lompre{at}egm.u-psud.fr

Little is known regarding the molecular mechanisms of atherogenicity of triglyceride-rich lipoproteins such as very low-density lipoproteins (VLDLs). We examined the effect of VLDL on proliferation of rat aortic smooth muscle cells, intracellular Ca2+ handling, and activity of cAMP-responsive element binding protein (CREB) and nuclear factor of activated T cells (NFAT) transcription factors. VLDL, isolated from human serum, dose- and time-dependently promoted proliferation. After 4 hours of exposure to VLDL (0.15 g/L proteins), the caffeine-induced Ca2+ release was inhibited and the IP3-sensitive Ca2+ release induced by ATP (10 µmol/L) was markedly prolonged. In quiescent cells, CREB was phosphorylated (pCREB) and NFAT was present in the cytosol, whereas in cells exposed to VLDL for 4 to 24 hours, pCREB disappeared and NFAT was translocated to the nucleus. VLDL-induced NFAT translocation and proliferation were blocked by cyclosporin A and LY294002 involving calcineurin and phosphatidylinositol 3-kinase (PI3K) pathways. Indeed, VLDLs rapidly phosphorylate protein kinase B and glycogen synthase kinase-3ß in a PI3K-dependent way. These results provide the first evidence that VLDLs induce smooth muscle cell proliferation by activating the PI3K pathway and nuclear NFAT translocation. Blockade of the Ca2+-induced Ca2+ release mechanism and dephosphorylation of pCREB contribute but were not sufficient to induce a proliferating phenotype.


Key Words: vascular disease • smooth muscle • calcium signaling • transcription factors • lipoproteins




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
L. Lipskaia, C. Pinet, Y. Fromes, S. Hatem, I. Cantaloube, A. Coulombe, and A.-M. Lompre
Mutation of {delta}-Sarcoglycan Is Associated with Ca2+-Dependent Vascular Remodeling in the Syrian Hamster
Am. J. Pathol., July 1, 2007; 171(1): 162 - 171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. I. Jabr, A. J. Wilson, M. H. Riddervold, A. H. Jenkins, B. A. Perrino, and L. H. Clapp
Nuclear translocation of calcineurin Abeta but not calcineurin A{alpha} by platelet-derived growth factor in rat aortic smooth muscle
Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2213 - C2225.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Nilsson, L. M. Nilsson, Y.-W. Chen, J. D. Molkentin, D. Erlinge, and M. F. Gomez
High Glucose Activates Nuclear Factor of Activated T Cells in Native Vascular Smooth Muscle
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 794 - 800.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. A. Barlow, P. Rose, R. A. Pulver-Kaste, and K. M. Lounsbury
Excitation-transcription coupling in smooth muscle
J. Physiol., January 1, 2006; 570(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. K. Wilkerson, T. J. Heppner, A. D. Bonev, and M. T. Nelson
Inositol trisphosphate receptor calcium release is required for cerebral artery smooth muscle cell proliferation
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H240 - H247.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Lipskaia, F. del Monte, T. Capiod, S. Yacoubi, L. Hadri, M. Hours, R. J. Hajjar, and A.-M. Lompre
Sarco/Endoplasmic Reticulum Ca2+-ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat
Circ. Res., September 2, 2005; 97(5): 488 - 495.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. C. Jackson, Z. Mi, and E. K. Jackson
Modulation of Cyclic AMP Production by Signal Transduction Pathways in Preglomerular Microvessels and Microvascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 349 - 358.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. A. Zaichuk, E. H. Shroff, R. Emmanuel, S. Filleur, T. Nelius, and O. V. Volpert
Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition
J. Exp. Med., June 7, 2004; 199(11): 1513 - 1522.
[Abstract] [Full Text] [PDF]